<DOC>
	<DOCNO>NCT02741765</DOCNO>
	<brief_summary>This feasibility exploratory study consist two part : first , cross-sectional ( one-time ) biomarker measurement compare BDNF-TrkB ( Brain-derived neurotrophic factor ( BDNF ) receptor , TrkB , ) signal cortical plasticity patient diagnose Parkinson 's Disease ( PD ) vs. healthy control match age . Second , prospective , randomize , double blind trial Transcranial Magnetic Stimulation ( TMS ) MAGSTIM Rapid2 Therapy System ( TMS ) ( real Sham ) aerobic exercise . This exploratory feasibility study look BDNF-TrkB signal cortical plasticity .</brief_summary>
	<brief_title>Exercise Transcranial Magnetic Stimulation : Increasing Brain Plasticity Parkinson 's Disease</brief_title>
	<detailed_description>Twenty-four PD patient ( n=24 ) randomly assign receive one two intervention duration two week . In Group 1 , subject participate daily session sham-rTMS follow supervised aerobic exercise ( Sham rTMS+Aerobic ) ; Group 2 , subject participate combination rTMS supervise aerobic exercise ( Real rTMS+Aerobic ) . Serum BDNF-TrkB signal lymphocyte TMS-based electrophysiological measure LTP-like plasticity measure . A comparison measure group patient PD group age-matched control ( n=12 ) analyze establish effect disease indices plasticity .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Diagnosis PD accord UK Brain Bank Criteria , confirm neurologist expertise movement disorder ; Hoehn Yahr stage II III ; On stable medication regimen since least 2 week prior enrolment study , view treat neurologist , unlikely require medication adjustment follow 36 month . Inclusion Criteria ( Healthy Controls ) Male Female ; age 3585 Exclusion Criteria ( Healthy Controls ) History seizure disorder , include febrile seizure ; Neurological disorder include PD , stroke , traumatic brain injury , faint spell syncope unknown cause ( ) ; Major unstable medical illness ; Pacemakers , neurostimulators , tattoos metal foreign body head area ( dental filling allow ) ; Untreated depression , score &gt; 20 Beck Depression Inventory II ; Taking follow medication within six week prior start study : imipramine , amitriptyline , doxepin , nortriptyline , maprotiline , chlorpromazine , clozapine , foscarnet , ganciclovir , ritonavir , theophylline , calcium channel blocker , beta blocker , tadalafil , vardenafil , avanafil , sildenafil ; Diagnosis dementia , Montreal Cognitive Assessment ( MoCA ) &lt; 20 ; Any clinically significant abnormality vital sign Cardiopulmonary limitation : untreated high blood pressure , history heart insufficiency ( class IIIII ) , coronary vascular disease , angina , arrhythmia , dyspnea exertion asthma</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Transcranial Magnetic Stimulation</keyword>
	<keyword>Exercise</keyword>
	<keyword>Brain Plasticity</keyword>
</DOC>